Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that hair loss in Indian women is not significantly linked to anemia or thyroid problems, but checking thyroid function could help those with ongoing hair loss.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Patients with chronic renal failure on hemodialysis often have skin problems like dry skin, itching, and nail changes.

The hair of two ancient Chilean mummies is well-preserved and contains high levels of heavy metals.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

ATE is linked to FAA, and treatment depends on cause; minoxidil helps, finasteride may worsen.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Bariatric surgery helps with weight loss but can cause complications and nutritional deficiencies.

Hair changes can indicate systemic diseases or medication effects.

Many dermatologists in Saudi Arabia recommend vitamins and minerals for hair loss, often based on personal experience rather than strong evidence.

Low serum ferritin levels are linked to hair loss in women.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Heavy metals might contribute to hair loss in Telogen Effluvium.

Hereditary elliptocytosis causes elongated red blood cells and can lead to mild or no symptoms.

Up to 50% of scalp hair can be lost before it appears thin, and treatment is only needed for hair loss caused by diseases or deficiencies.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

The article concludes that treating hair loss requires careful research, understanding the causes, and personalized treatment plans.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Trichotillomania is a challenging-to-treat impulse-control disorder where individuals pull out their hair, more common in females, with some treatments showing benefits.

A toddler with a rash and developmental delays improved after treatment for severe malnutrition caused by a diet lacking in protein.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

DDS treatment for LABD can cause severe side effects like anemia and hair loss, requiring careful monitoring.

Low serum ferritin levels are not closely linked to telogen effluvium in women.

A 66-year-old woman with skin lesions and other symptoms improved after treatment for porphyria cutanea tarda.

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

Correcting trace element imbalances may help reduce alopecia areata symptoms.

A supplement with Serenoa repens improved hair loss in a patient.

The document concludes that understanding hair loss and its psychological impact is crucial for physicians to provide effective counseling and treatment to patients.

Stopping steroids and providing supportive care improved the patient's Cushing Syndrome symptoms and ulcers.